The phrase "acquire full control" is correct and usable in written English.
It can be used in contexts where someone is seeking to gain complete authority or dominance over a situation, organization, or resource.
Example: "The company aims to acquire full control of the market by the end of the fiscal year."
Alternatives: "gain complete control" or "obtain total control".
The President pledged to him that the civilians would acquire full control.
In August, Glencore launched a $280m bid to acquire full control of Minara where it already held 73%.
Viacom Inc. yesterday made a deal to acquire full control of the UPN television network, setting up the prospect that one company would own two broadcast television networks for the first time.
He added, "While they won't admit it, we believe News Corp. was always likely to eventually decide to sell its stake in BSkyB if it cannot acquire full control".
Jeremy Hunt, the culture secretary, was the main victim.Mr Hunt's misfortunes stem from the Murdochs' bid to acquire full control of BSkyB, a British satellite broadcaster, beginning in 2010.
It has since sold part of its stake at a loss to reduce debt.Now it is trying to acquire full control of Hochtief, the world's tenth-biggest construction firm.
Accountant and corporate financier Noel Kingston has acquired full control of Midland Tyre Services, in the country's largest commercial tyre deal.
But John Browne, BP's chief executive, announced plans to eliminate overlapping outlets and said BP could save $200 million a year if it acquires full control of the German operations.
The Times Company acquired full control of The Herald Tribune in 2003, and has been accelerating the integration of the two papers in recent months.
Sprint is also close to acquiring full control of Clearwire, whose wireless spectrum holdings will go toward building its own high-speed data network.
AstraZeneca confirmed that it was acquiring full control of Cambridge Antibody Technology Group in a deal worth £567 million ($1.07 billion), intended to secure the drug maker's access to new products.
